Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Alex A. Adjei 1 Article
Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
Cancer Res Treat. 2022;54(2):315-329.   Published online February 18, 2022
DOI: https://doi.org/10.4143/crt.2022.078
AbstractAbstract PDFPubReaderePub
Precision oncology has fundamentally changed how we diagnose and treat cancer. In recent years, there has been a significant change in the management of patients with oncogene-addicted advanced-stage NSCLC. Increasing amounts of identifiable oncogene drivers have led to the development of molecularly targeted drugs. Undoubtedly, the future of thoracic oncology is shifting toward increased molecular testing and the use of targeted therapies. For the most part, these novel drugs have proven to be safe and effective. As with all great innovations, targeted therapies pose unique challenges. Drug toxicities, resistance, access, and costs are some of the expected obstacles that will need to be addressed. This review highlights some of the major challenges in the use of targeted therapies in NSCLC and provides guidance for the future strategies.

Citations

Citations to this article as recorded by  
  • A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center
    Andrea M. Russell, Allison P. Pack, Stacy C. Bailey, Christine B. Weldon, Marie S. Dreyer, Sheetal M. Kircher, Michael S. Wolf
    Cancer.2024; 130(12): 2085.     CrossRef
  • Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib
    Areeba Fareed, Nabiha Amir, Humna Ajaz, Afra Sohail, Rayyan Vaid, Solay Farhat
    International Journal of Surgery.2024; 110(4): 1891.     CrossRef
  • Drug Repurposing: Exploring Potential Anti-Cancer Strategies by Targeting Cancer Signalling Pathways
    Natalia Haddad, Sara Magura Gamaethige, Nadine Wehida, Ahmed Elbediwy
    Biology.2024; 13(6): 386.     CrossRef
  • Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers
    Avinash Khadela, Kaivalya Megha, Vraj B Shah, Shruti Soni, Aayushi C Shah, Hetvi Mistry, Shelly Bhatt, Manthan Merja
    Clinical Medicine Insights: Oncology.2024;[Epub]     CrossRef
  • Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018
    Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy
    Jian Wang, Ming Zhang, Xin You, Yang Xu, Congcong Zhang, Ying Li, Chunhui Yang, Qi Wang
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Next-generation sequencing impact on cancer care: applications, challenges, and future directions
    Mariano Zalis, Gilson Gabriel Viana Veloso, Pedro Nazareth Aguiar Jr., Nathalia Gimenes, Marina Xavier Reis, Silvio Matsas, Carlos Gil Ferreira
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • Expression and Functional Analysis of Immuno-Micro-RNAs mir-146a and mir-326 in Colorectal Cancer
    Ovidiu Farc, Liviuta Budisan, Florin Zaharie, Roman Țăulean, Dan Vălean, Elena Talvan, Ioana Berindan Neagoe, Oana Zănoagă, Cornelia Braicu, Victor Cristea
    Current Issues in Molecular Biology.2024; 46(7): 7065.     CrossRef
  • Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
    Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, David Horne, Jyoti Malhotra, Ravi Salgia, Sharad S. Singhal
    Journal of Clinical Medicine.2024; 13(14): 4189.     CrossRef
  • Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil
    Vania Hungria, Anna Sureda, Garcia Rosario Campelo, Marco Aurélio Salvino, Karthik Ramasamy
    Cancers.2024; 16(17): 3063.     CrossRef
  • Non-small-cell lung cancer
    Lizza E. L. Hendriks, Jordi Remon, Corinne Faivre-Finn, Marina C. Garassino, John V. Heymach, Keith M. Kerr, Daniel S. W. Tan, Giulia Veronesi, Martin Reck
    Nature Reviews Disease Primers.2024;[Epub]     CrossRef
  • A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer
    David Planchard, Jürgen Wolf, Benjamin Solomon, Martin Sebastian, Martin Wermke, Rebecca S. Heist, Jong-Mu Sun, Tae Min Kim, Noemi Reguart, Miguel F. Sanmamed, Enriqueta Felip, Pilar Garrido, Armando Santoro, Douglas Bootle, Xuân-Mai Couillebault, Anil Ga
    Lung Cancer.2024; 197: 107964.     CrossRef
  • CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling
    Ying Yi, Lingfeng Dai, Yaqin Lan, Changyuan Tan, Dania M. Vázquez-Blomquist, Guirong Zeng, Dejian Jiang, Ke Yang, Silvio E. Perea, Yasser Perera
    Scientific Reports.2024;[Epub]     CrossRef
  • Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database
    Marco Alifano, Elisa Daffré, Laurent Brouchet, Pierre Emmanuel Falcoz, Françoise Le Pimpec Barthes, Pierre Benoit Pages, Pascal Alexandre Thomas, Marcel Dahan, Raphael Porcher
    The Lancet Regional Health - Europe.2023; 26: 100566.     CrossRef
  • Proteolysis targeting chimeras in non-small cell lung cancer
    Garo Hagopian, Christopher Grant, Misako Nagasaka
    Cancer Treatment Reviews.2023; 117: 102561.     CrossRef
  • Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration
    Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang, Xin-Ying Ji
    iScience.2023; 26(8): 107321.     CrossRef
  • Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
    Giulia Maria Stella, Sara Lettieri, Davide Piloni, Ilaria Ferrarotti, Fabio Perrotta, Angelo Guido Corsico, Chandra Bortolotto
    Pharmaceuticals.2023; 16(7): 1042.     CrossRef
  • Recent advances in non-small cell lung cancer targeted therapy; an update review
    Mahmood Araghi, Reza Mannani, Ali Heidarnejad maleki, Adel Hamidi, Samaneh Rostami, Salar Hozhabri Safa, Fatemeh Faramarzi, Sahar Khorasani, Mina Alimohammadi, Safa Tahmasebi, Reza Akhavan-Sigari
    Cancer Cell International.2023;[Epub]     CrossRef
  • AXL transcriptionally up-regulates TMEM14A expression to mediate cell proliferation in non-small-cell lung cancer cells
    Te-Hsuan Jang, Sheng-Chieh Lin, Ya-Yu Yang, Shu-Hui Wu, Tsu-Hsiang Kuo, Shuang-En Chuang
    Biochemical and Biophysical Research Communications.2023; 682: 365.     CrossRef
  • Applications of nanofibers drug delivery system in cancer therapy
    Nafiu Aminu, Salim Ilyasu, Mohammed Al-Kassim Hassan, Fatima Shuaibu Kurfi, Abubakar Ibrahim Jatau, Siok-Yee Chan, Deghinmotei Alfred-Ugbenbo
    Journal of Drug Delivery Science and Technology.2023; 90: 105128.     CrossRef
  • Exploring the Anticancer Potential of Origanum majorana Essential Oil Monoterpenes Alone and in Combination against Non-Small Cell Lung Cancer
    Kholoud Arafat, Aya Mudhafar Al-Azawi, Shahrazad Sulaiman, Samir Attoub
    Nutrients.2023; 15(23): 5010.     CrossRef
  • Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin–Yang Balance
    Mi-Kyung Jeong, Jaemoo Chun, In-Jae Oh
    Journal of Clinical Medicine.2022; 11(15): 4275.     CrossRef
  • Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies
    Ricardo Teixo, Ana Salomé Pires, Eurico Pereira, Beatriz Serambeque, Inês Alexandra Marques, Mafalda Laranjo, Slavko Mojsilović, Roberto Gramignoli, Peter Ponsaerts, Andreina Schoeberlein, Maria Filomena Botelho
    International Journal of Molecular Sciences.2022; 23(15): 8570.     CrossRef
  • Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
    Wei-Yu Yang, Yu He, Qikang Hu, Muyun Peng, Zhe Zhang, Shouzhi Xie, Fenglei Yu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Molecular targeted therapy for anticancer treatment
    Hye-Young Min, Ho-Young Lee
    Experimental & Molecular Medicine.2022; 54(10): 1670.     CrossRef
  • Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer
    Audrey Brisebarre, Julien Ancel, Théophile Ponchel, Emma Loeffler, Adeline Germain, Véronique Dalstein, Valérian Dormoy, Anne Durlach, Gonzague Delepine, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
    George V. Pérez, Mauro Rosales, Ailyn C. Ramón, Arielis Rodríguez-Ulloa, Vladimir Besada, Luis J. González, Daylen Aguilar, Dania Vázquez-Blomquist, Viviana Falcón, Evelin Caballero, Paulo C. Carvalho, Rodrigo Soares Caldeira, Ke Yang, Yasser Perera, Silv
    Biomedicines.2022; 11(1): 43.     CrossRef
  • 11,947 View
  • 304 Download
  • 27 Web of Science
  • 27 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP